Drug intelligence / Profile preview

N-(5-Isopropyl-thiazol-2-yl)-2-pyridin-3-yl-acetamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-(5-Isopropyl-thiazol‐2‐YL)‐2‐pyridin‐3‐YL‐acetamide is a synthetic small molecule belonging to the class of pyridine derivatives. It features a thiazole ring substituted with an isopropyl group and an acetamide linker to a pyridine moiety. The compound has been identified as an inhibitor of cyclin-dependent kinase 2 (CDK2), which plays a key role in cell cycle regulation by controlling the transition from G1 to S phase. By inhibiting CDK2 activity, this molecule may have potential applications in cancer research or other proliferative disorders where CDK dysregulation is implicated[1][8]. There are no known approved therapeutic indications or marketed formulations for this compound.

Other names
N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamideN-(5-(propan-2-yl)-1,3-thiazol-2-yl)-2-(pyridin-3-yl)acetamideN-[5-(propan-2‑yl)-1,3‑thiazol‑2‑yl]-2‑(pyridin‑3‑yl)acetamideN-(5-propan‑2‑yl–1,3–thiazol–2–yl)–2-pyridin–3–ylacetamide
02

Targets

CDK2 (Cyclin-dependent kinase 2)

Beyond the preview

Go deeper on N-(5-Isopropyl-thiazol-2-yl)-2-pyridin-3-yl-acetamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(5-Isopropyl-thiazol-2-yl)-2-pyridin-3-yl-acetamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call